Three States consider raising penalties for exposure to HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Three States consider raising penalties for exposure to HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

AIDS Policy Law. 1997 Jun 27;12(12):1, 5. Unique Identifier : AIDSLINE MED/97702691


Abstract: Lawmakers in California, New Jersey, and Alaska voted to impose stronger penalties on individuals who expose others to HIV through sex or drug needles. Each of the three States' senates voted to approve stronger penalties based on high profile cases involving men who knowingly transmitted HIV to women, or threatened to do so. Earlier this year, Florida and Washington State raised the penalty for the crime of intentional exposure. In California, Senate Bill 705 would make it a felony for an infected individual to infect others intentionally. The current bill is supported by law enforcement as well as victims rights organizations. In New Jersey, the senate voted unanimously to increase the penalty for knowingly exposing another person to HIV, syphilis, gonorrhea, and other sexually transmitted diseases. The Alaska bill makes it a class B felony for exposing another individual to HIV through sexual activity, drug needles, or donation of body parts or fluids.
Keywords: *Crime/LEGISLATION & JURISPRUD *Criminal Law *HIV Infections/TRANSMISSION *Public Policy *Sex BehaviorKWDcrime/legislation&jurisprudKWDcriminallawKWDhivinfections/transmissionKWDpublicpolicyKWDsexbehavior
971030
M97A1292

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .